Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000136570107000032/f8kregardingpromissorynotesa.htm
August 2011
June 2011
February 2009
November 2008
September 2008
September 2008
August 2008
July 2008
June 2008
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1084966/000136570107000032/f8kregardingpromissorynotesa.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Abviva Inc.
Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:
CIK: 1084966Events:
Form Type: 8-K Corporate News
Accession Number: 0001365701-07-000032
Submitted to the SEC: Wed Dec 19 2007 8:25:59 PM EST
Accepted by the SEC: Thu Dec 20 2007
Period: Wednesday, October 3, 2007
Industry: Medical Laboratories